Bronchial intraepithelial neoplasia/early central airways lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition)

Timothy C. Kennedy, Annette McWilliams, Eric Edell, Tom Sutedja, Gordon Downie, Rex Yung, Adi Gazdar, Praveen N. Mathur

Research output: Contribution to journalArticle

76 Citations (Scopus)

Abstract

Background: An evidence-based approach is necessary for the localization and management of intraepithelial and microinvasive non-small cell lung cancer in the central airways. Methods: Material appropriate to this topic was obtained by literature search of a computerized database. Recommendations were developed by the writing committee and then reviewed by the entire guidelines panel. The final recommendations were made by the Chair and were voted on by the entire committee. Results: White light bronchoscopy has diagnostic limitations in the detection of microinvasive lesions. Autofluorescence bronchoscopy (AFB) is a technique that has been shown to be a sensitive method for detecting these lesions. In patients with moderate dysplasia or worse on sputum cytology and normal chest radiographic findings, bronchoscopy should be performed. If moderate/severe dysplasia or carcinoma in situ (CIS) is detected in the central airways, then bronchoscopic surveillance is recommended. The use of AFB is preferred if available. In a patient being considered for curative endobronchial therapy to treat microinvasive lesions, AFB is useful. A number of endobronchial techniques as therapeutic options are available for the management of CIS and can be recommended to patients with inoperable disease. In patients with operable disease, surgery remains the mainstay of treatment, although patients may be counseled about these techniques. Conclusions: AFB is a useful tool for the localization of microinvasive neoplasia. A number of endobronchial techniques available for the curative treatment can be considered first-line therapy in inoperable cases. For operable cases, the techniques may be considered and discussed with the patients.

Original languageEnglish (US)
Pages (from-to)221S-233S
JournalChest
Volume132
Issue number3 SUPPL.
DOIs
StatePublished - Jan 1 2007

Fingerprint

Evidence-Based Practice
Bronchoscopy
Practice Guidelines
Lung Neoplasms
Neoplasms
Carcinoma in Situ
Therapeutics
Sputum
Non-Small Cell Lung Carcinoma
Cell Biology
Thorax
Databases
Guidelines
Light

Keywords

  • Angiogenic squamous dysplasia
  • Autofluorescence bronchoscopy
  • Carcinoma in situ
  • Fiberoptic bronchoscopy
  • Nd-YAG
  • Photodynamic therapy
  • Radiographically occult lung cancer

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine
  • Cardiology and Cardiovascular Medicine

Cite this

Bronchial intraepithelial neoplasia/early central airways lung cancer : ACCP evidence-based clinical practice guidelines (2nd edition). / Kennedy, Timothy C.; McWilliams, Annette; Edell, Eric; Sutedja, Tom; Downie, Gordon; Yung, Rex; Gazdar, Adi; Mathur, Praveen N.

In: Chest, Vol. 132, No. 3 SUPPL., 01.01.2007, p. 221S-233S.

Research output: Contribution to journalArticle

Kennedy, TC, McWilliams, A, Edell, E, Sutedja, T, Downie, G, Yung, R, Gazdar, A & Mathur, PN 2007, 'Bronchial intraepithelial neoplasia/early central airways lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition)', Chest, vol. 132, no. 3 SUPPL., pp. 221S-233S. https://doi.org/10.1378/chest.07-1377
Kennedy, Timothy C. ; McWilliams, Annette ; Edell, Eric ; Sutedja, Tom ; Downie, Gordon ; Yung, Rex ; Gazdar, Adi ; Mathur, Praveen N. / Bronchial intraepithelial neoplasia/early central airways lung cancer : ACCP evidence-based clinical practice guidelines (2nd edition). In: Chest. 2007 ; Vol. 132, No. 3 SUPPL. pp. 221S-233S.
@article{5e2d02dbbf6e42daa39dd08873a300f9,
title = "Bronchial intraepithelial neoplasia/early central airways lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition)",
abstract = "Background: An evidence-based approach is necessary for the localization and management of intraepithelial and microinvasive non-small cell lung cancer in the central airways. Methods: Material appropriate to this topic was obtained by literature search of a computerized database. Recommendations were developed by the writing committee and then reviewed by the entire guidelines panel. The final recommendations were made by the Chair and were voted on by the entire committee. Results: White light bronchoscopy has diagnostic limitations in the detection of microinvasive lesions. Autofluorescence bronchoscopy (AFB) is a technique that has been shown to be a sensitive method for detecting these lesions. In patients with moderate dysplasia or worse on sputum cytology and normal chest radiographic findings, bronchoscopy should be performed. If moderate/severe dysplasia or carcinoma in situ (CIS) is detected in the central airways, then bronchoscopic surveillance is recommended. The use of AFB is preferred if available. In a patient being considered for curative endobronchial therapy to treat microinvasive lesions, AFB is useful. A number of endobronchial techniques as therapeutic options are available for the management of CIS and can be recommended to patients with inoperable disease. In patients with operable disease, surgery remains the mainstay of treatment, although patients may be counseled about these techniques. Conclusions: AFB is a useful tool for the localization of microinvasive neoplasia. A number of endobronchial techniques available for the curative treatment can be considered first-line therapy in inoperable cases. For operable cases, the techniques may be considered and discussed with the patients.",
keywords = "Angiogenic squamous dysplasia, Autofluorescence bronchoscopy, Carcinoma in situ, Fiberoptic bronchoscopy, Nd-YAG, Photodynamic therapy, Radiographically occult lung cancer",
author = "Kennedy, {Timothy C.} and Annette McWilliams and Eric Edell and Tom Sutedja and Gordon Downie and Rex Yung and Adi Gazdar and Mathur, {Praveen N.}",
year = "2007",
month = "1",
day = "1",
doi = "10.1378/chest.07-1377",
language = "English (US)",
volume = "132",
pages = "221S--233S",
journal = "Chest",
issn = "0012-3692",
publisher = "American College of Chest Physicians",
number = "3 SUPPL.",

}

TY - JOUR

T1 - Bronchial intraepithelial neoplasia/early central airways lung cancer

T2 - ACCP evidence-based clinical practice guidelines (2nd edition)

AU - Kennedy, Timothy C.

AU - McWilliams, Annette

AU - Edell, Eric

AU - Sutedja, Tom

AU - Downie, Gordon

AU - Yung, Rex

AU - Gazdar, Adi

AU - Mathur, Praveen N.

PY - 2007/1/1

Y1 - 2007/1/1

N2 - Background: An evidence-based approach is necessary for the localization and management of intraepithelial and microinvasive non-small cell lung cancer in the central airways. Methods: Material appropriate to this topic was obtained by literature search of a computerized database. Recommendations were developed by the writing committee and then reviewed by the entire guidelines panel. The final recommendations were made by the Chair and were voted on by the entire committee. Results: White light bronchoscopy has diagnostic limitations in the detection of microinvasive lesions. Autofluorescence bronchoscopy (AFB) is a technique that has been shown to be a sensitive method for detecting these lesions. In patients with moderate dysplasia or worse on sputum cytology and normal chest radiographic findings, bronchoscopy should be performed. If moderate/severe dysplasia or carcinoma in situ (CIS) is detected in the central airways, then bronchoscopic surveillance is recommended. The use of AFB is preferred if available. In a patient being considered for curative endobronchial therapy to treat microinvasive lesions, AFB is useful. A number of endobronchial techniques as therapeutic options are available for the management of CIS and can be recommended to patients with inoperable disease. In patients with operable disease, surgery remains the mainstay of treatment, although patients may be counseled about these techniques. Conclusions: AFB is a useful tool for the localization of microinvasive neoplasia. A number of endobronchial techniques available for the curative treatment can be considered first-line therapy in inoperable cases. For operable cases, the techniques may be considered and discussed with the patients.

AB - Background: An evidence-based approach is necessary for the localization and management of intraepithelial and microinvasive non-small cell lung cancer in the central airways. Methods: Material appropriate to this topic was obtained by literature search of a computerized database. Recommendations were developed by the writing committee and then reviewed by the entire guidelines panel. The final recommendations were made by the Chair and were voted on by the entire committee. Results: White light bronchoscopy has diagnostic limitations in the detection of microinvasive lesions. Autofluorescence bronchoscopy (AFB) is a technique that has been shown to be a sensitive method for detecting these lesions. In patients with moderate dysplasia or worse on sputum cytology and normal chest radiographic findings, bronchoscopy should be performed. If moderate/severe dysplasia or carcinoma in situ (CIS) is detected in the central airways, then bronchoscopic surveillance is recommended. The use of AFB is preferred if available. In a patient being considered for curative endobronchial therapy to treat microinvasive lesions, AFB is useful. A number of endobronchial techniques as therapeutic options are available for the management of CIS and can be recommended to patients with inoperable disease. In patients with operable disease, surgery remains the mainstay of treatment, although patients may be counseled about these techniques. Conclusions: AFB is a useful tool for the localization of microinvasive neoplasia. A number of endobronchial techniques available for the curative treatment can be considered first-line therapy in inoperable cases. For operable cases, the techniques may be considered and discussed with the patients.

KW - Angiogenic squamous dysplasia

KW - Autofluorescence bronchoscopy

KW - Carcinoma in situ

KW - Fiberoptic bronchoscopy

KW - Nd-YAG

KW - Photodynamic therapy

KW - Radiographically occult lung cancer

UR - http://www.scopus.com/inward/record.url?scp=34848858514&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34848858514&partnerID=8YFLogxK

U2 - 10.1378/chest.07-1377

DO - 10.1378/chest.07-1377

M3 - Article

C2 - 17873170

AN - SCOPUS:34848858514

VL - 132

SP - 221S-233S

JO - Chest

JF - Chest

SN - 0012-3692

IS - 3 SUPPL.

ER -